Fibroblast activation protein (FAP) is one of the most extensively studied and promising targets for cancer diagnosis and therapy. Although small-molecule FAP-targeting radiopharmaceuticals are widely used, their clinical utility is often limited by rapid tumor washout and suboptimal therapeutic efficacy. To address th...
Zhi-Tao Guo, Yi-Lin Zeng, Zhen-Feng Liu et al.· European journal of medicina...· 0 citations
Abstract Accurate prediction of peptide–major histocompatibility complex (pMHC) binding is central to understanding antigen presentation and identifying T-cell epitopes in cancer immunotherapy. Although recent methods have achieved notable progress, most approaches rely predominantly on sequence-based features and only...
Wen-Fan Chen, Ying Chi, Yi-Hao Wang et al.· Briefings in Bioinformatics· 0 citations
Applications of plasmonic nanopores for molecular sequencing remain limited by poorly controlled translocation dynamics and predominantly single-pass readout. Here, we propose an in-plane heterostructure architecture that integrates molecular transport, confinement, and surface-enhanced Raman scattering (SERS) readou...
Li-Jun Meng, Shi-Tong Zhang, M. Qiu et al.· Nano letters (Print)· 0 citations
A pioneering multi-modal framework with TCR-peptide-HLA sequence and structure features incorporating an attention mechanism designed to accurately identify tumor antigens with immunogenic properties, which presents a brand-new and promising approach for cancer immunotherapies that target tumor antigens.
It is demonstrated that both dataset quality and data quantity contribute to model performance and, notably, that retaining molecules with incomplete stereochemical information can outperform their removal when the resulting gain in data quantity offsets the quality penalty.